Endocrine management of male subfertility
- PMID: 24251201
- PMCID: PMC3830347
- DOI: 10.4103/2230-8210.119500
Endocrine management of male subfertility
Abstract
Infertility in a couple is defined as failure to conceive after 12 months of regular unprotected intercourses. Male infertility due to impaired spermatogenesis may result from hypothalamic, pituitary or testicular disorders. Medical management of infertility associated with gonadotropin deficiencies have high success rate, but for primary testicular failure assisted reproduction techniques (ART) with adjunctive endocrine manipulation remains the best therapeutic option. This article discusses various therapeutic options and regimes using gonadotropins, anti-estrgens, aromatase inhibitors in management of male subfertiltiy.
Keywords: Hypogonadotropic hypogonadism; male subfertiltiy; oligo-azoospermia.
Conflict of interest statement
References
-
- Bhasin S. Approach to the infertile man. J Clin Endocrinol Metab. 2007;92:1995–2004. - PubMed
-
- Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF., Jr Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:4128–36. - PubMed
-
- Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: A prospective, controlled, randomized clinical study. Fertil Steril. 2005;84:654–61. - PubMed
-
- Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev. 2000;2:CD000151. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources